REQUEST A DEMO
Total
USD $0.00
Search more companies

"Nordic Pharma" Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: "Nordic Pharma" Sp. z o.o. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Nordic Pharma" Sp. z o.o. is a company based in Poland, with its head office in Jablonna. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The company was established on April 04, 2006. During that time, "Nordic Pharma" Sp. z o.o.’s total assets decreased by 0.54%.

Headquarters
Ul. Rekreacyjna 4
Jablonna; Mazowieckie; Postal Code: 05-110

Contact Details: Purchase the "Nordic Pharma" Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the "Nordic Pharma" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Nordic Pharma" Sp. z o.o. report to view the information.
Incorporation Date:
April 04, 2006
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
99.9%
Purchase this report to view the information.
0.1%
Company Performance
Financial values in the chart are available after "Nordic Pharma" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-60.35%
Operating profit (EBIT)
0.36%
Net Profit (Loss) for the Period
0.36%
Total assets
-0.54%
Total equity
-21.17%
Return on Equity (ROE)
-3.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?